A Review of Commercial and Medical-Grade Physiological Monitoring Devices for Biofeedback-Assisted Quality of Life Improvement Studies by Nogueira, Pedro et al.
A Review of Commercial and Medical-Grade Physiological Monitoring
Devices for Biofeedback-Assisted Quality of Life Improvement Studies
Pedro Nogueira1,2 & Joana Urbano1,2 & Luís Paulo Reis1,3 & Henrique Lopes Cardoso1,2 & Daniel Castro Silva1,2 &
Ana Paula Rocha1,2 & Joaquim Gonçalves4 & Brígida Mónica Faria1,5
Abstract
With the rise in wearable technology and Bhealth culture^, we are seeing an increasing interest and affordances in
studying how to not only prolong life expectancy but also in how to improve individuals’ quality of life. On the one
hand, this attempts to give meaning to the increasing life expectancy, as living above a certain threshold of pain and lack
of autonomy or mobility is both degrading and unfair. On the other hand, it lowers the cost of continuous care, as
individuals with high quality of life indexes tend to have lower hospital readmissions or secondary complications, not to
mention higher physical and mental health. In this paper, we evaluate the current state of the art in physiological therapy
(biofeedback) along with the existing medical grade and consumer grade hardware for physiological research. We
provide a quick primer on the most commonly monitored physiologic metrics, as well as a brief discussion on the
current state of the art in biofeedback-assisted medical applications. We then go on to present a comparative analysis
between medical and consumer grade biofeedback devices and discuss the hardware specifications and potential prac-
tical applications of each consumer grade device in terms of functionality and adaptability for controlled (laboratory) and
uncontrolled (field) studies. We end this article with some empirical observations based on our study so that readers
might use take them into consideration when arranging a laboratory or real-world experience, thus avoiding costly time
delays and material expenditures.
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Introduction
Originally starting with fitness watches and more recently
with the advent of smartphone-powered fitness applications,
recent years have seen an increase in the prevalence and com-
plexity of wearable technology. This technological advance-
ment has been made possible by the miniaturization of sensor
technology and increased battery/circuit efficiency, which has
been driven by an exponentially growing healthcare and
Bhealth culture^ [1, 2].
One of the main reasons for the emergence of this Bhealth
culture^ is the result of an increasing life expectancy of pa-
tients, which often isn’t accompanied by their quality of life
(QoL), thus leaving patients with great pain, restricted mobil-
ity and considerable adverse effects to their daily life and
future health prospects. In other words, beyond prolonging
life, it is essential to also increase patient’s quality of life.
Quality of life is now considered an important aspect in
clinical practice for patients with chronic illnesses, as some-
one with poor QoL indexes will likely suffer from a lack of
mobility (due to, for example, joint pain), which in turn leads
to low exercise and/or lowmental health levels. These, in turn,
slowly chip away at their health condition, aggravating their
condition in a feedback loop and increase the overall risk of
developing secondary health conditions.
Despite its overarching importance, the current methods to
assess quality of life, automatic or semi-automatic, and its use
in clinical decision support systems are still underexplored
and there are virtually no applications in the market for this.
As a first step in developing a structured approach towards
building such systems, in this paper we evaluate the existing
state of the art in biometric analysis systems – both medical
and consumer grade –, as well as existing biomedical studies
on Quality of Life measurements and model building via bio-
metric analysis. The paper is thus structured as follows:
Section 2 describes the most common physiological metrics,
as well as the current state of the art in biofeedback studies.
Following this discussion, Section 3 expands on the previous
topic by presenting the existing medical studies on Quality of
Life improvements via biofeedback techniques. In Section 4,
we discuss the existing medical and consumer grade devices
in the market today. Section 5 concludes the paper by present-
ing an inter and intra device comparison, elaborating on the
benefits and disadvantages of the uses of the presented devices
for the purpose of measuring quality of life, and also offers
some suggestions for their applicability to these studies.
Biometric data collection
The most objective way to evaluate quality of life is to monitor
patients’ physiological state over a relatively long period of time
(ranging from weeks to, ideally, months). The most common
way of doing this is through biofeedback techniques.
Biofeedback itself was originally developed for medicinal pur-
poses in the 1970s as a training procedure to overcome medical
conditions, such as Attention deficit hyperactivity disorder
(ADHD) [2]. However, in the last decade, it has re-emerged as
a viable technology for use in ludic applications and some re-
searchers have leveraged this by integrating biofeedback into
interactive training or rehabilitation applications [3, 4]. This
Bsugar coating^ makes the process more natural and less strenu-
ous or boring for patients and can thus increase both the amount
of data collected, as well as the efficiency of the program itself.
Despite this growing popularity, biofeedback apparatus is
often medical-grade, and thus, expensive (ranging from $6000
to $15,000+ for a single device), meaning it is not readily
available to the public or easy to apply to large studies.
Several hardware manufacturers are attempting to provide in-
expensive physiological input solutions that use brain signals
(e.g., Emotiv Epoc1, Neurosky Mindset2, OCZ Neural
Impulse Actuator3) and other physiological measures, such
as skin conductance, oximetry, electromyography, respiration
rates, and electrocardiography (e.g., BITalino4).
Throughout this section, we provide a review of the most
current technology and research with regards to biofeedback
for medical purposes. We begin however, with a short primer
of physiological metrics prior to discussing these applications
and the existing industry hardware.
A primer on physiological metrics
Electrodermal activity Electrodermal activity (EDA), usually
measured in the form of skin conductance (SC), is a common
measure of skin conductivity. EDA arises as a direct conse-
quence of the activity of eccrine (sweat) glands. Some of these
glands situated at specific locations (e.g., palms of the hands
and feet soles) respond to psychological changes and thus
EDA/SC measured at these sites reflects emotional changes
as well as cognitive activity [4]. SC has been linearly corre-
lated with arousal [3, 5–7] and extensively used as stress in-
dicator [8], in emotion recognition [3, 8–10] and to explore
correlations between gameplay dimensions [11, 12]. It is usu-
ally measured using two Ag/AgCL surface sensors snapped to
two Velcro straps placed around the middle and index fingers
of the non-dominant hand [7] but consumer-based hardware
usually measures it on the wrist using metallic contacts, which
reduces accuracy but is, understandably, a necessary trade-off.
Cardiovascular measures The cardiovascular system is com-
posed by the set of organs that regulate the body’s blood flow.
1 https://www.emotiv.com/epoc/
2 http://neurosky.com/
3 https://www.ocz.com/us/
4 http://bitalino.com/en/
Various metrics for its activity currently exist, among which
some of the most popular ones are: blood pressure (BP), blood
volume pulse (BVP) and heart rate (HR). Deriving from the
BVP or HR, various secondary measures can be extracted,
such as inter-beat interval (IBI) and heart rate variability
(HRV). HR is usually correlated with arousal or physical ex-
ercise and can be easily differentiated using a combination of
other sensors like, for example, skin conductivity [7]. HR,
along with its derivate and HRV has also been suggested to
distinguish between positive and negative emotional states
(valence) [8, 9]. Heart rate is a very commonmeasure for most
sports watches and fitness bracelets and is usually measured
via a photoplethysmogram (the volumetric measurement of an
organ) using a pulse oximeter that illuminates the skin and
measures changes in light absorption. For medical grade de-
vices, the preferred method is to usually infer this from a raw
ECG data stream (more precise) or the participants’ BVP
readings using a finger sensor (less precise).
Electromyography Electromyography (EMG) is a method for
measuring the electrical potentials generated by contraction of
muscles [7]. Facial EMG has been successfully used to distin-
guish valence in gameplay experiences [10]. In the former
experiences, Hazlett describes the zygomaticus major
(cheek) muscle as significantly more active during positive
events and the corrugator supercilii (brow) muscle as more
active in negatively-valenced events.
Respiration A Respiration sensor (RESP) measures the vol-
ume of air contained in an individual’s lungs, as well as their
breathing patterns. It is usually measured using a sensitive
girth sensor stretched across the individual’s chest [7]. It can
be inferred indirectly through other methods such as an accel-
erometer or gyroscope but results are dependent on the uses
and easily muddied by high physical movement so it is not
advised on high precision scenarios.
Body temperature Body temperature (TMP) sensors are, in
the vast majority of cases, highly-sensitive (able to measure
changes up to a fraction of a Celsius degree) thermally sensi-
tive resistors. These are quite cheap to create, consume a low
energy output and are extremely small and easy to integrate
within a watch or wearable technology. They represent one of
the few cases where there is virtually no relevant difference
between medical and consumer grade devices.
Medical biofeedback applications
As previously mentioned, originally biofeedback was de-
signed to aid in medical therapy by helping patients overcome
medical conditions or to perform patient monitoring/
assessment [13, 14]. For example, a music therapy approach
is presented by Dong et al. [14], where the users’ negative
emotional states are counterbalanced through music. In a sim-
ilar approach, in [15] the authors presented a system to aid
body balance rehabilitation by using simple audio frequencies
to indicate correct posture. In related work, Huang et al. de-
veloped a neural motor rehabilitation biofeedback system for
use in a virtual 3D world [16].
Due to biofeedback’s easy integration with interactive and
multimedia applications, various serious games have been de-
signed to aid in the treatment of medical conditions. For ex-
ample, a game was presented which targets the treatment of
swallowing dysfunctions [13]. Riva et al. proposed a General
Anxiety Disorder treatment that triggers changes in the game
world based on the patient’s heart rate and skin conductance
[17]. Avery similar biofeedback game (BNevermind^) for fear
management based on players’ heart rate readings was also
designed [18].
Several approaches gearedmore towards self-improvement
have also been proposed. For example, BBrainball^ [19] and
Bersak’s proposed racing game [15] are relax-to-win indirect
biofeedback games that introduce a competitive player-
versus-player environment where the most relaxed player
has a competitive advantage. While entertaining, the most
interesting aspect of these games is their paradoxical design,
because they combine two opposing concepts — relaxation
and competitiveness. Naturally, in a competitive environment,
players feel pressured to win. In turn, this hinders their ability
to relax, which further puts them at a disadvantage and thus,
under more pressure. This leads to a positive feedback cycle
where the first player to achieve a competitive advantage tends
to have increasingly higher odds of winning and thus benefits
self-control and brain stimulation – a key factor in mental
health and, therefore, quality of life.
Table 1 presents a comparative analysis of clinical biofeed-
back applications. For each work, we show the number of
subjects used in the study (SS – sample size), the biofeedback
type used (monitoring, direct biofeedback (DFB) or indirect
biofeedback (IFB)), the adaptation mechanisms employed/
driven by the physiologic data, area of application for the
study, and finally the list of sensors used (BP = Blood
P r e s s u r e , EMG = E l e c t r om y o g r a p h y, E EG =
Electroencephalography, ACC = Accelerometer, PPG =
Photoplethysmography, HR = Heart Rate, SC = Skin
Conductivity).
Biofeedback for quality of life measurement
and modelling
With increased life expectancy and overall survival rates in
most diseases, as well as improved general living conditions,
quality of life has become an important issue for most people.
In healthcare, not only is the success of treating or managing a
disease important but also the impact it has on the individual.
Many people prefer death to a life without a level of quality
they have become accustomed to. This makes it paramount to
assess the quality of life of the individual, and how to improve
it. With quality of life being an imprecise definition and de-
pendent on the individual, it becomes necessary to develop
models to understand and measure quality of life.
In [23], Wilson and Cleary describe a conceptual model for
patient’s quality of life improvement after medical procedures
and/or therapies. They also address the fact that different pa-
tients respond differently to the same metrics, putting forth
that this is a subjective metric that is not only influenced by
the treatment itself, but also by how it is administered (e.g.
patients being under the notion that they are constantly being
monitored might make them feel more secure and thus less
stressed about their own wellbeing, which in turn can lead to a
more positive outcome regardless of treatment efficiency be-
ing the same with or without physiological monitoring).
Sprangers and Schwartz [24] present another QoL theoret-
ical model to help patients cope with chronic or sudden life-
threatening illnesses via ‘response shift’. The model contem-
plates not only the patient’s response to his health issue and
subsequent treatment but also catalysts for it, antecedents,
coping mechanisms and response shift (self-evaluation adap-
tation methods). The authors also point at the possibility of "a
dynamic feedback loop aimed at maintaining or improving the
perception of QoL" as future work that would drastically in-
crease the effectiveness of QoL on these studies.
In [25], Felce and Perry discuss another theoretical QoL
model based on a multidimensional analysis involving five
dimensions: physical wellbeing, material wellbeing, social
wellbeing, emotional wellbeing, and development and activi-
ty. It also allows/accounts for objective comparisons to be
made between particular groups of individuals and what is
normative.
Taillefer et al. [26] present a thorough review of theory-
driven models of health-related QoL based on how well they
tackle the methodological and conceptual problems in the
field. The authors reviewed 68 models formulated from
1965 to 2001 based on a blind judge scheme that analyzed
a) how sophisticated the models’ conceptualization was; b) its
definition of QoL; c) the distinction between factors that in-
fluence QoL; and d) the presence and/or usage of suitable
instruments to measure QoL objectively. A grading scheme
was introduced and interesting key points of this analysis re-
vealed that 25% of authors did not define QoL per se and that
while 78% of authors identified instruments to measure QoL,
from the authors’ analysis, none seemed to provide results
based on actual measurements, much less based on large
groups of low QoL patients on a continuous monitoring
protocol.
In recent years, QoL has been defined as a measure of self-
perception and its evaluation is performed through question-
naires. In the case of QoLRH (Quality of Life Related with
Health) more than one questionnaire is normally used. There
are dozens of questionnaires for QoL assessment that evaluate
different QoL perspectives. The fact that these questionnaires
are usually long and also the periodicity of administration
(usually once a week or once a month, depending on the
questionnaire) causes the respondents to give up on
responding in a ponderedmanner, filling up the questionnaires
in an careless manner, biasing the answers and, consequently,
invalidating the measure. By way of example, the SF36V2
questionnaire has 36 questions and should be administered
once a month and the EORTC-QLQC30 has 30 questions
and should be administered once a week.
Thus, the use of questionnaires is incompatible with con-
tinuous monitoring, and biofeedback is profiled as an excel-
lent alternative to the use of questionnaires mainly due to the
almost non-existent intrusion into the individual’s routines.
Most studies on quality of life have been focused on
chronical diseases or others that somehow have a high impact
on the patient’s lifestyle, and sometimes requires the patient to
make changes to life habits. In cancer in particular, QOL has
been studies for more than three decades, with research works
Table 1 Review of 10 medical and therapeutic applications of biofeedback techniques
Reference SS BF Type Adaptations Treatment Sensors
Blanchard [20] 42 Monitoring Thermal feedback Elevated BP BP
Bryant [13] 1 Monitoring Muscle exercise regimen feedback Swallowing Dysfunctions EMG
Dong [14] 4 IBF Musical excerpts Music Therapy EEG
Rocchi [21] 8 IBF Audio Frequencies Balance Control ACC
Huang [16] 2 IBF Musical and Visual Stimuli Motor Rehabilitation ACC, PPG
Stepp [22] 6 DBF Control virtual fish Swallowing Dysfunctions EMG
Riva [18] 24 IBF Virtual object placement and properties General Anxiety Disorder HR, SC
Reynolds [18] NA IBF Audiovisual stimuli (game events) Fear / Anxiety Disorders HR
Hjelm [19] NA IBF Ball movement / orientation Relax to win EEG
Bersak [15] NA IBF Car acceleration Relax to win SC
focused on particular cancer types and the impact on the indi-
vidual quality of life [27–31], as well as more general research
works by Aaronson [32] and Rehse [33].
Other diseases that cause social anxiety and discomfort,
like constipation and fecal and/or urinary incontinence, have
also been the target of several studies, to understand the im-
pact the course of treatment has in the patient’s life [34–40].
On a perhaps less evident or physical level, mental disor-
ders and respective treatments also have a huge impact on the
individual’s perceived quality of life, and have also been stud-
ies focused on studying its nefarious effects on both the pa-
tients and their kin [41–43].
While most of these diseases affect a small percentage of
the population, there are some conditions that either for a short
or long-term affect most individuals. For example, Ahmedzai
[44] has studied the impact of pain control on chronic pain
patients and its influence on their quality of life, while Lasek
and Chren [45] present a study on the impact of acne in adult
quality of life, discussing mostly the mental trauma associated
with it. These studies provide evidence that patients with se-
rious medical conditions are not the only ones to benefit from
the proposed monitoring systems and that there are suitable
applications for a wider (perhaps mass) public. While the
moral merits of such pursuit might not be obvious, the eco-
nomic traction it entails might very well be a driving force
behind further advances on this field.
Medical and consumer biofeedback devices
As seen above, biofeedback was originally developed for
medical research applications, having only gained widespread
traction in recent years. Thus, most of the existing state of the
art research has been developed using medical grade devices,
which essentially make no compromises in terms of accuracy
but are somewhat lacking in practicality. Conversely, consum-
er grade biofeedback sensors, such as the ones present in
modern fitness or lifestyle trackers, focus heavily on being
Beveryday usable^ and trade sensor accuracy for other conve-
niences such as unobtrusiveness and battery life.
In this section, we start by succinctly describing the
capabilities of the best-of-breed medical grade biofeed-
back hardware. We do so in order to contextualize the
existing standard for sensor accuracy and hardware fea-
tures so that we can establish a baseline for comparing
consumer grade devices not only among themselves but
also to the current state of the art. As our target study
essentially requires research-level quality readings but al-
so the amenities of everyday usability and autonomy, this
is a necessary comparison. We then proceed to describe
the most popular consumer grade devices before moving
towards a comparative analysis and applicability consid-
erations on the Discussion section.
Medical grade devices
Medical grade devices are designed with the goal of offering
versatile but mostly highly advanced systems for physiologi-
cal research. Most of them share the same technical specifica-
tions – as is required by strict medical guidelines – and hard-
ware format – for compliance and competition purposes. The
most popular solution on the market are the devices
manufactured and sold by Mind Media BV, more specifically,
the Nexus-105 series.
The Nexus-10 offers 8 input channels in total, with their
configuration being customizable by the users for a particular
set of sensors, depending on the study to be conducted. Mind
Media offers a wide range of modalities that can be simulta-
neously measured. These include: electroencephalography
(EEG), slow cortical potentials (SCP), electromyography
(EMG), electrooculography (EOG), electrocardiography
(ECG), blood flow via blood volume pulse (BVP), oximetry
(O2), skin conductance (SC), respiration patterns (RSP), body
temperature (TMP), accelerometer (ACC) and force sensors
(FS).
From these, a wide range of secondary or processed vari-
ables can be extracted (e.g. heart rate, heart rate variability,
breathing patterns, brainwave features, etc.) using the includ-
ed software suite which is able to capture, collect and present
the sensor data in real-time. It also allows users to configure
custom dashboards and apply real-time filters to the data prior
to logging them in several custom, text-based formats – in-
cluding raw data outputs via Bluetooth to external
applications.
On the practical side, the Nexus-10 (and all of its compet-
itors) presents a simple but heavy data acquisition solution,
roughly the size of a human hand (120x140x45 mm) and
weighing around 500 g.While not too bulky, it is cumbersome
and noticeable in every usage, especially if the patient is mov-
ing around or doing physical activity. Older versions of these
devices were powered by 2 to 4 triple-A batteries, which
lasted for roughly 10 h of capture with Bluetooth streaming
active. Recent versions include a lithium-ion battery pack
(8000 mAh lithium polymer) that reduces weight and should
last for over 24 h, also making charging the device on the fly a
possibility, which greatly helps in both lab and field studies.
Regarding sensor accuracy and sampling rates, the Nexus-
10 series offers high quality medical grade connectors that
isolate noise or artifacts when touching or pulling on them.
The biggest source of noise is usually on the attaching surface
sensors that, if not properly tightened/adhered, will provide
erroneous readings. In terms of electrical interference, the car-
bon coating on the cables shields them and the active noise
cancellation technology helps ameliorate the issues. Sampling
rates are also the highest in the business with dual channel
5 https://www.mindmedia.com/products/nexus-10-mkii/
inputs (ECG, EMG, EEG) recording data at 2048 Hz and
single channel inputs (SC, BVP, TMP) and derived readings
(e.g. HR) recording at 32 Hz.
In terms of sheer performance and autonomy, as wewill see
in the following section, the Nexus has essentially the edge
over consumer grade devices. Where it loses ground is mainly
in cost and its inability to offer a more compact package (most
consumer grade devices are less than half of its weight and a
fraction of the size). A single unit complete with the necessary
cables and pre-gelled electrodes can easily cost over 8000€,
which is enough to buy, on average, over 40 consumer grade
devices and makes it highly inadequate for large or unsuper-
vised studies.
Consumer grade devices
Unlike medical grade devices, designed for high-end research,
consumer biofeedback is a recent trend that has been focused
on ludic activities (e.g. biofeedback videogames), fitness
tracking and lifestyle monitoring. Most of the available de-
vices on the market have appeared in the last 4–5 years, hav-
ing been made possible by 1) the miniaturization and mass
production of sensor technology, mostly due to the advent of
smartphones, and 2) by the increasing prevalence of Bhealth
cultures^ and popular awareness of the importance of physical
and mental well-being. In this section we evaluate eight con-
sumer grade physiological recording devices, each from dif-
ferent manufacturers. We focus on the latest version of each of
them and discuss them individually. In the following section,
we present a comparative analysis between each of the con-
sumer grade devices as well as how they stack up to medical
grade devices. We will analyze the following dimensions:
& Price
& Available sensors
& Derived variables
& Existing API
& Software Suite
& Operating System Compatibility
& Communication protocols
& Battery Life
The first device on our list is the Feel Wristband from Feel.
It retails for $199 and is designed to log emotion patterns
throughout the day. How it achieves this is not described, as
the algorithm is understandably proprietary, but there is an
evident lack of scientific research backing this claim, which
raises doubts as to its accuracy. From the available informa-
tion on their website, it is evident they use skin conductivity,
which has been shown to directly correlate with arousal [4] –
one of the main emotional dimensions in Russell’s circumplex
model of affect. They also use a 3D accelerometer to track
physical activity, and in all likelihood correct improper SC
activations due to exercise; it is also likely they are computing
the subject’s heart rate for this. The biggest issue with this
emotional detection process is that there is no discernable
way of identifying valence – the second dimension in
Russell’s circumplex model – and without it, it is impossible
to distinguish the emotion’s positive or negative charge, only
it’s intensity. Secondly, an important distinction should be
made between emotional states and emotions, as they are quite
different. An emotional state is a coordinate in an N-
dimensional emotional space (e.g. Russell’s Arousal-Valence
Cartesian space). It is an objective quantification but lacks
context. An emotion on the other hand is not so well defined
as it is more of a quickly shifting mood that relies heavily on
context. For example, a high arousal, low valence emotional
state can represent any emotion that has high energy/
excitement and a very negative charge to it, such as for exam-
ple, Terror, Stress or Anxiety. All of these emotions fall within
the same emotional region. However, what emotion the emo-
tional state translates to is highly dependent on context. This is
a common issue with virtually all of the devices discussed in
this section and manufacturers seem to be aware of this short-
coming so they often rely on the user to provide contextual
information not only to do a black-box approach towards rec-
ognizing emotions in future dates but also as a fallback (and
potentially psychological induction method) to validate their
readings. The issue is not necessarily crippling to the usage of
the device but lays itself to some doubts and thus, is not suit-
able for academic research.
The second device on our list is the Zenta Wristband6 by
Vinaya. It retails for $50 less than the Feel Wristband 7($149)
and offers the same general functionality with a significant
amount of extra sensors. Overall, it presents SC, TMP, and
O2 sensors. It also comes with an accelerometer and a micro-
phone. From the included sensors it derives an impressing
number of variables: HR, HRV, RSP, pulse transit time and
pulse wave velocity, as well as a few higher-level ones, such
as discrete emotions, calorie tracking and activity tracking.
Both emotion prediction and calorie tracking require user in-
put (overall mood and daily caloric intake, respectively).
Our third entry is the Microsoft Band 28, which is, by far,
the most complete package on the market at the time of writ-
ing. It retails for the same price as the Feel Wristband ($199)
but offers the following biometric sensors: SC, O2, and TMP.
It also includes GPS, an ambient light sensor, a Gyroscope in
addition to the standard accelerometer, an UV sensor, a ba-
rometer, and a microphone. It can compute the user’s HR from
the O2 sensor but it is not clear as to why RSP readings are not
described on the technical sheet. It presents itself as the most
6 https://www.indiegogo.com/projects/zenta-stress-emotion-management-on-
your-wrist
7 https://www.myfeel.co/
8 https://www.microsoft.com/en-us/band
research-focused solution on the market and does not offer
discrete emotion processing. It does however, act as a fitness
tracker so it measures calorie intake/expenditure, sleep pat-
terns and sleep quality analysis tools. It is also the only device
on the market that offers a dedicated visualization and data
processing suite (Microsoft Health), which is free of charge.
The fourth and fifth entries are the Basis Peak 9and
Jawbone UP310. They retail for $199 and $129 but, oddly,
the Basis Peak offers less sensors as it comes only with a O2
from which it derives BVP and HR and a gyroscope and
accelerometer. The Jawbone on the other hand offers the same
O2 sensor in conjunction with SC and TMP sensors from
which it derives HR and RSP measures. It only includes an
accelerometer but not a gyroscope. In terms of fitness track-
ing, both track caloric intake and expenditure, as well as sleep
patterns, their quality and physical activity. None of them offer
any data visualization platform or APIs to read the data in real-
time.
The last three entries in our list are not necessarily wearable
or dedicated biometric tracking platforms but aim to tackle the
market through sheer volume or a low cost/personalization.
The first of these is the AppleWatch 211, which retails starting
at $269 and offers HR and RSP measurements though
photoplethysmographic measurement and GPS tracking. The
second platform is the Android counterpart to the Apple
Watch, the Android Wear 212. Contrary to the Apple Watch,
the Android Wear is free and is composed of the SDK to
develop wearable apps so it doesn’t offer a dedicated hardware
platform. As such, it is not possible to assess which sensors it
offers. The biggest advantage to both of these platforms is that
while they don’t do most of the work for the user, they enable
tech-savvy users and researchers to build their own applica-
tions from scratch and completely customize them, while also
allowing them to access data in real-time and integrate with
other existing apps on the marketplace to leverage their func-
tionality. In short, they have the biggest potential. The main
issue is the limited range of sensors on these wearable plat-
forms, which can severely hinder the data collection ability. In
this regards, the Android Wear has the edge as it can integrate
with any compatible platform.
The final entry on our list, BITalino, addresses the main
disadvantages seen on the consumer grade segment by offer-
ing a hybrid solution between these and medical grade de-
vices. BITalino is an Arduino-based biometric solution de-
signed for researchers and electronics/engineering hobbyists
that want to build their own physiologic recording devices. It
retails from $149 to $200 for the most complete pack, which
includes all the necessary hardware, as well as cables and
sensors for measuring ECG, EMG, EEC, SC and acceleration.
At the moment it seems it doesn’t have a temperature sensor
available but these are readily available online and can be
easily integrated into the platform. It offers a free and com-
plete software suite (Open Signals) to visualize and process
data offline or in real-time and can perform relatively complex
signal and statistical analysis, as well as process the collected
data to infer HR, HRVand RSPmetrics. It is not as practical as
most of the devices on the market and is not waterproof or
water resistant as all of the devices discussed so far but, over-
all, it is possibly the most versatile and cost-efficient solution
on the market.
Discussion
In this section we analyze each of the devices discussed on the
two previous sections and compare them in terms of: (1)
Features: BHow complete is the device and how much data
can it produce?^ (2) Signal Processing: BHow much signal
processing (e.g., filtering, noise reduction) does the device
allow or require to extract meaningful information?^ (3)
Precision: BHow accurately can the signal be interpreted
for both raw and derived measures and how much noise in-
terference is present?^ (4) Sensor Reliability: BHow likely is
the sensor to fail and how much calibration does it require?^
(5) Intrusiveness: BWould the required apparatus interfere
with the daily lives of the candidates, potentially impairing
the study or biasing it in any significant way?^ (6)
Practicality: BHow long does the device’s battery last and at
what sampling rates?^ and (7) Cost: BBased on the current
retail prices, what would be the necessary budget to perform a
medium-sized study (50-100 individuals)?^
Table 2 presents a breakdown of the described devices in
detail. It summarizes our previous discussion and allows us to
quickly reference them for the purposes of this discussion.
Regarding the pure number of features (volume of data),
most devices generate roughly the same outputs: HR, SC and
some form of activity tracking via accelerometers or gyro-
scopes. The clear winners are the Microsoft Band 2 and
BITalino platforms, which not only include all these outputs
but also include a few not present on the competing devices.
We observe the same pattern in terms or derived variables and
available analysis tools as these are the only two devices that
offer proper visualization, logging and analysis software for
the collected data.
In terms of precision, it is difficult to evaluate how these
devices will fare without a large, controlled field study with all
of them but, in general, all devices gather data in the sameway
and feature similar sensors and sensor placements so, if prop-
erly used, results should not differ significantly. In terms of
how it compares with medical-grade devices, it should be
expected that more movement or electromagnetic interference
9 https://sleeptrackers.io/basis-peak/
10 https://jawbone.com/fitness-tracker/up3
11 https://www.apple.com/lae/watch/
12 https://www.android.com/wear/
be created given that these are lower grade devices, which can
be alleviated with proper filtering. However, the greatest
drawback is the fact that given that the sensors are placed in
less-than-ideal body locations (e.g. SC should be measured in
the index and middle fingers and most devices measure it on
the wrist [4]), it makes the sensors prone to data collection
failures, which in turn make the data stream incomplete and,
ultimately, unusable. This is also aggravated by the longer-
term nature of the study. As data has to be collected with as
little flaws as possible over a long period of time, it is highly
possible that patients will improperly readjust the sensors and
not provide proper data.
This leads us into our fifth point, intrusiveness. While most
devices, being worn on the wrist and being lightweight, are
generally not very intrusive, none of them are waterproof and
have been reported to be somewhat frail in terms of construc-
tion due to the sensor miniaturization. There have also been
cases of user complaints regarding some minor discomfort
when using them for prolonged times due to the blood flow
restrictions or sensors digging into the wrist area. There was
even a recall action on one of them due to the O2 sensor
causing skin burns when used for long periods of time. This
is also tied to practicality and another point of concern is the
lack of substantial autonomy – all devices use a rechargeable
LiPo battery that lasts anywhere between 24 and 96 h – and
this implies either reducing the sampling rates to a bare min-
imum (e.g. 1 Hz or 5–10 min samples at 32 Hz per hour) or
creating data collection pauses for charging the devices.
Whether this is a pain point depends heavily on the focus of
the study but should be carefully considered as it can put in
question the validity of the study itself.
Our final analysis point concerns price and here all devices
are generally within the same price range so there is not much
discussion to be had. Clearly, the most attractively priced ones
are the Jawbone UP3 and BITalino due to the sheer sensor/
price ratio and the least attractive one is the Apple Watch 2.
However, the differences in available sensors are basically nil
when comparing between consumer and medical grade de-
vices, so the main question should be whether medical grade
devices’ signal quality is needed and, if not, which devices are
available for shipping on the market.
When considering all points, it seems clear that the most
complete and versatile packages are the Microsoft Band 2
(MB2) and BITalino platforms. Where they differ is the fact
that the MB2 does not require any significant assembly or
coding to start collecting data and is much less intrusive than
the BITalino. On the other hand, the BITalino offers a very
complete package that, bar the higher signal precision, rivals
medical grade devices. All in all, it is not possible to define the
Bbest^ device, as this will depend on the myriad of experimen-
tal conditions that are imposed by the study and need to be
factored into the equation. Conditions such as sampling fre-
quency, raw data output or processing capabilities, levels of
acceptable intrusiveness or budget constraints, among others,
can be decisive factors when choosing the device to use.
Given our own experiences with these devices we would,
however, note that while on paper the MB2 is the most attrac-
tive from the price and number of sensors perspective, in
reality, using these devices is riddled with constant issues on
a day-to-day basis. Part of the issue is that these are only
second-generation devices that have neither seen a wide adop-
tion (and as a result, somewhat poor improvement cycles from
the manufacturer) and that while they allow for access to the
data they collect, this is not their focus and thus custom utility
programs – and sometimes even hacks – are required to keep
them running at the desired sampling frequencies and obtain
the unprocessed data. The truth is that if budget is an issue but
the time frame and man-hours allow for it, they can be a viable
option but the lack of wide adoption and strict industry stan-
dards (usually present in medical grade devices) make the data
Table 2. Breakdown of currently existing consumer-grade physiological devices
Device Name Price Sensors / Raw Variables Derived Variables API Suite OS Comm Battery Life
Feel Wristband $199 SC, HR, Acc Emotions Log App iOS/Android 48h, LiPo
Zenta Wristband $149 SC, Tmp, HR, HRV,
RSP, Acc, Noise
Emotions, calories,
pulse wave/patterns
Log App iOS/Android 48h, LiPo
Microsoft Band 2 $199 SC, HR, Light, UV, Tmp,
Gyro, Barometer, GPS,
Noise
Calories, sleep
tracking
Log MS Health iOS/Android 48h, LiPo
Basis Peak $199 BVP, HR, Gyro Calories, sleep
tracking
Log App iOS/Android 96h, LiPo
Jawbone UP3 $129 SC, BVP, HR, Tmp, Acc Calories, sleep
tracking
Log App Desktop Bluetooth 48h, LiPo
Apple Watch 2 $300 HR, GPS Activity tracking SDK 3rd Party Apps iOS 24h, LiPo
Android Wear 2 $150+ NA NA SDK 3rd Party Apps iOS/Android NA
BITalino $149+ ECG, EMG, EEG,
SC, Acc
HRV, Signal filtering SDK Open Signals Desktop iOS/
Android
NA
questionable from a scientific perspective, forcing the research
team to substantiate it with comparative analyses and empiri-
cal studies to corroborate their findings.
Given all of this and the above, our opinion is that, for most
scientific purposes, medical grade devices should be favored
as they are superior in terms of data acquisition, quality, un-
foreseen failure rates and industry standards/certifications. If
they are not an option due to budget or practical concerns the
BITalino platform seems to be the best choice (assuming a
technical team is present in-house) for the following situa-
tions: a) there is an option to do the study in a controlled or
laboratory environment, b) there is a need to collect a wide
range of physiological signals, c) signal quality should be
medical grade but budget is a depriving factor and/or d) prac-
ticality can be somewhat compromised upon. For all other
cases where practicality is a concern and there is no need to
collect more complex physiological data such as EMG or
EEG, the MB2 seems to be the best available option on the
consumer device market.
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